MAPT and frontotemporal dementia: In a study evaluating CSF soluble TREM2 levels in patients with genetic FTD including different mutations, only patients carrying GRN mutation showed higher levels than controls, and TREM2 values correlated with total tau as a marker of neuronal injury [128].